Journal of Kerman University of Medical Sciences

Current Issue

By Issue

By Author

Author Index

Keyword Index

About Journal

Aims and Scope

JKMU Ethical Policies

Indexing and Abstracting

Related Links

FAQ

Peer Review Process

News

Metric

Editorial Policies

Data Sharing Policy

The Importance of Extended-Spectrum β-lactamases in Gram-Negative Enteric Bacilli and the Phenotypic Methods of detection

Authors

1 Assistant Professor, Department of Microbiology, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

2 Professor, Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

3 Associate Professor, Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

4 Assistant Professor, Department of Microbiology, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

5 Assistant Professor, Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran

6 Professor, Department of Microbiology, School of Medicine, Kerman University of Medical Sciences, Kerman, Iran

Abstract

The production of β-lactamase enzymes is the main mechanism of resistance to β-lactam antibiotics in gramnegative bacilli. Therefore, it is important to identify the β-lactamases-producing bacteria for the treatment of caused infections. This article aimed to review the recent literature and guidelines regarding phenotypic detection of β-lactamases in common gram-negative bacilli in clinical samples.

Keywords

References
  1. Kohanski MA, Dwyer DJ, Collin JJ. How antibiotics kill bacteria: from targets to networks. Nat Rev Microbiol 2010; 8(6): 423-35.
  2. Pfeifer Y, Cullik A, Witte W. Resistance to cephalosporins and carbapenems in Gram-negative bacterial pathogens. Int J Med Microbiol 2010; 300(6): 371-9.
  3. Saga T, Yamaguchi K. History of antimicrobial agents and resistant bacteria. JMAJ 2009; 52(2): 103-8.
  4. Jacoby G, Munoz-Price LS. The new ß-lactamases. N Engl J Med 2005; 352(380): 91.
  5. Bush K, Jacoby GA. Updated functional classification of ß-lactamases. Antimicrob Agents Chemother 2010; 54(3): 969-76.
  6. Strateva T, Yordanov D. Pseudomonas aeruginosa - a phenomenon of bacterial resistance. J Med Microbiol 2009; 58(Pt 9): 1133-48.
  7. Perez F, Endimiani A, Hujer KM, Bonomo RA. The continuing challenge of ESBLs. Curr Opin Pharmacol 2007; 7(5): 459-69.
  8. Weldhagen GF, Poirel L, Nordmann P. Ambler class A extended-spectrum beta-lactamases in Pseudomonas aeruginosa: novel developments and clinical impact. Antimicrob Agents Chemother 2003; 47(8): 2385-92.
  9. Poole K. Resistance to ß-lactam antibiotics. Cell Mol Life Sci 2004; 61(17): 2200-23.
  10. Samaha-Kfoury JN, Araj GF. Recent developments in beta-lactamases and extended spectrum beta-lactamases. BMJ 2003; 327(7425): 1209-13.
  11. Bush K. Characterization of ß-lactamases. Antimicrob Agents Chemother 1989; 33(3): 259-63.
  12. Paterson DL, Bonomo RA. Extended-spectrum ß-lactamases: a clinical update. Clin Microbiol Rev 2005; 18(4): 657-86.
  13. Livermore DM. Beta-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995; 8(4): 557-84.
  14. Weldhagen GF. GES: an emerging family of extended spectrum ß-lactamases. Clinical Microbiology Newsletter 2006; 28(19): 145-9.
  15. Sundin D. Hidden ß-lactamases in the enterobacteriaceae – dropping the extra disks for detection, part II. Clinical Microbiology Newsletter 2009; 31(7): 47-52.
  16. Denton M. Enterobacteriaceae. Int J Antimicrob Agents 2007; 29(Suppl 3): S9-S22.
  17. Kalantar D, Mansouri S. Emergence of multiple ß-lactamases produced by Escherichia coli clinical isolates from hospitalized patient in Kerman, Iran. Jundishapur J Microbiol 2010; 3(4): 137-45.
  18. British Society for Antimicrobial Chemotherapy. Detection of extended-spectrum b-lactamases (ESBLs) in E. coli and Klebsiella species [Online]. [Cited 2012]; Available from: URL: http://bsac.org.uk/wp-content/uploads/ 2012/ 02/Ecoli klebsiella.
  19. Walther-Rasmussen J, Hoiby N. Cefotaximases (CTX-M-ases), an expanding family of extended-spectrum β-lactamases. Can J Microbiol 2004; 50(3): 137-65.
  20. Patel JB, Rasheed JK, Kitchel B. Carbapenemases in enterobacteriaceae: activity, epidemiology, and laboratory detection. Clinical Microbiology Newsletter 2009; 31(8): 55-62.
  21. Poirel L, Nordmann P, Lagrutta E. Emergence of KPC-Producing Pseudomonas aeruginosa in the United States. Antimicrob Agents Chemother 2010; 54(7): 3027.
  22. Kitchel B, Rasheed JK, Endimiani A, Hujer AM, Anderson KF, Bonomo RA, et al. Genetic factors associated with elevated carbapenem resistance in KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother 2010; 54(10): 4201-7.
  23. Walsh TR. Emerging carbapenemases: a global perspective. Int J Antimicrob Agents 2010; 36(Suppl 3): S8-14.
  24. Poole K. Pseudomonas aeruginosa: resistance to the max. Front Microbiol 2011; 2: 65.
  25. Falagas ME, Karageorgopoulos DE. Extended-spectrum beta-lactamase-producing organisms. J Hosp Infect 2009; 73(4): 345-54.
  26. Shlaes DM. New beta-lactam-beta-lactamase inhibitor combinations in clinical development. Ann N Y Acad Sci 2013; 1277: 105-14.
  27. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing. Wayne, PA: Clinical and Laboratory Standards Institute; 2014.
  28. Mansouri S, Kalantar D, Asadollahi P, Taherikalani M, Emaneini M. Characterization of Klebsiella pneumoniae strains producing extended spectrum beta-lactamases and AMPC type beta-lactamases isolated from hospitalized patients in Kerman, Iran. Roum Arch Microbiol Immunol 2012; 71(2): 81-6.
  29. Mirsalehian A, Kalantar-Neyestanaki D, Nourijelyani K, Asadollahi K, Taherikalani M, Emaneini M, et al. Detection of AmpC-beta-lactamases producing isolates among carbapenem resistant P. aeruginosa isolated from burn patient. Iran J Microbiol 2014; 6(5): 306-10.
  30. Doi Y, Paterson DL. Detection of plasmid-mediated class C beta-lactamases. Int J Infect Dis 2007; 11(3): 191-7.
  31. Willems E, Verhaegen J, Magerman K, Nys S, Cartuyvels R. Towards a phenotypic screening strategy for emerging beta-lactamases in Gram-negative bacilli. Int J Antimicrob Agents 2013; 41(2): 99-109.
  32. Shahid M, Sobia F, Singh A, Khan HM, Hawkey PM, Huq A. AmpC β-lactamases and bacterial resistance: an updated mini review. Reviews in Medical Microbiology 2009; 20(3): 41-55.
  33. Lister PD, Wolter DJ, Hanson ND. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 2009; 22(4): 582-610.
  34. Rodriguez-Martinez JM, Poirel L, Nordmann P. Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2009; 53(11): 4783-8.
  35. Hanson ND. AmpC beta-lactamases: what do we need to know for the future? J Antimicrob Chemother 2003; 52(1): 2-4.
  36. Li J, Cheng J, Yin J, Zhang X, Gao F, Zhu Y, et al. Progress on AmpC ß-lactamases. Current Bioinformatics 2009; 4(3): 218-25.
  37. Papanicolaou GA, Medeiros AA, Jacoby GA. Novel plasmid-mediated beta-lactamase (MIR-1) conferring resistance to oxyimino- and alpha-methoxy beta-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1990; 34(11): 2200-9.
  38. Knothe H, Shah P, Krcmery V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983; 11(6): 315-7.
  39. Bauernfeind A, Chong Y, Schweighart S. Extended broad spectrum beta-lactamase in Klebsiella pneumoniae including resistance to cephamycins. Infection 1989; 17(5): 316-21.
  40. Jacoby GA. AmpC ß-lactamases. Clin Microbiol Rev 2009; 22(1): 161-82.
  41. Mansouri S, Neyestanaki DK, Shokoohi M, Halimi S, Beigverdi R, Rezagholezadeh F, et al. Characterization of AmpC, CTX-M and MBLs types of ß-lactamases in clinical isolates of Klebsiella pneumoniae and Escherichia coli producing Extended Spectrum ß-lactamases in Kerman, Iran. Jundishapur J Microbiol 2014; 7(2): e8756.
  42. Coudron PE. Inhibitor-based methods for detection of plasmid-mediated AmpC beta-lactamases in Klebsiella spp., Escherichia coli, and Proteus mirabilis. J Clin Microbiol 2005; 43(8): 4163-7.
  43. Black JA, Moland ES, Thomson KS. AmpC disk test for detection of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal AmpC beta-lactamases. J Clin Microbiol 2005; 43(7): 3110-3.
  44. Song W, Bae IK, Lee YN, Lee CH, Lee SH, Jeong SH. Detection of extended-spectrum ß-lactamases by using boronic acid as an AmpC ß-lactamase inhibitor in clinical isolates of Klebsiella spp. and Escherichia coli. J Clin Microbiol 2007; 45(4): 1180-4.
  45. Tsakris A, Kristo I, Poulou A, Themeli-Digalaki K, Ikonomidis A, Petropoulou D, et al. Evaluation of boronic acid disk tests for differentiating KPC-possessing Klebsiella pneumoniae isolates in the clinical laboratory. J Clin Microbiol 2009; 47(2): 362-7.
  46. Peter-Getzlaff S, Polsfuss S, Poledica M, Hombach M, Giger J, Bottger EC, et al. Detection of AmpC beta-lactamase in Escherichia coli: comparison of three phenotypic confirmation assays and genetic analysis. J Clin Microbiol 2011; 49(8): 2924-32.
  47. Kalantar D, Mansouri S, Razavi M. Emergence of imipenem resistance and presence of metallo-ß-lactamases enzymes in multi- drug resistant gram negative bacilli isolated from clinical samples in Kerman, 2007-2008. J Kerman Univ Med Sci 2010; 17(3): 208-14. [In Persian].
  48. Neyestanaki DK, Mirsalehian A, Rezagholizadeh F, Jabalameli F, Taherikalani M, Emaneini M. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients. Burns 2014; 40(8): 1556-61.
  49. Gupta V. Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species. Expert Opin Investig Drugs 2008; 17(2): 131-43.
  50. Tada T, Miyoshi-Akiyama T, Shimada K, Shimojima M, Kirikae T. IMP-43 and IMP-44 metallo-beta-lactamases with increased carbapenemase activities in multidrug-resistant Pseudomonas aeruginosa. Antimicrob Agents Chemother 2013; 57(9): 4427-32.
  51. Iraz M, Duzgun AO, Cicek AC, Bonnin RA, Ceylan A, Saral A, et al. Characterization of novel VIM carbapenemase, VIM-38, and first detection of GES-5 carbapenem-hydrolyzing beta-lactamases in Pseudomonas aeruginosa in Turkey. Diagn Microbiol Infect Dis 2014; 78(3): 292-4.
  52. Kalantar D, Jabalameli F, Emaneini M. The modified Hodge test for identification of Klebsiella pneumoniae carbapenemase producing isolates. Burns 2013; 39(2): 370-1.
  53. Pasteran F, Mendez T, Rapoport M, Guerriero L, Corso A. Controlling false-positive results obtained with the hodge and masuda assays for detection of class a carbapenemase in species of enterobacteriaceae by incorporating boronic Acid. J Clin Microbiol 2010; 48(4): 1323-32.
  54. Rai S, Manchanda V, Singh NP, Kaur IR. Zinc-dependent carbapenemases in clinical isolates of family Enterobacteriaceae. Indian J Med Microbiol 2011; 29(3): 275-9.
  55. Miriagou V, Papagiannitsis CC, Tzelepi E. Detecting VIM-1 production in proteus mirabilis by an imipenem-dipicolinic acid double disk synergy test? J Clin Microbiol 2010; 48(2): 667-8.
  56. Shin KS, Son BR, Hong SB, Kim J. Dipicolinic acid-based disk methods for detection of metallo-beta-lactamase-producing Pseudomonas spp. and Acinetobacter spp. Diagn Microbiol Infect Dis 2008; 62(1): 102-5.
  57. Kimura S, Ishii Y, Yamaguchi K. Evaluation of dipicolinic acid for detection of IMP- or VIM- type metallo-beta-lactamase-producing Pseudomonas aeruginosa clinical isolates. Diagn Microbiol Infect Dis 2005; 53(3): 241-4.
  58. Pandya NP, Prajapati SB, Mehta SJ, Kikani KM, Joshi PJ. Evaluation of various methods for detection of metallo-β-lactamase (mbl) production in gram negative bacilli. Int J Biol Med Res 2011; 2(3): 775-7.
  59. Mirsalehian A, Akbari Nakhjavani F, Bahador A, Jabal Ameli F, Bigverdi R, Goli H. Prevalence of MBL-producing Pseudomonas aeruginosa isolated from burn patients. Tehran Univ Med J 2011; 68(10): 563-9. [In Persian].


Journal of Kerman University of Medical Sciences
Volume 23, Issue 3
July and August 2016
Pages 380-405
Files
Share
How to cite
Statistics